Maria Tevar-Luque

Cordoba, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs.

Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 15, 2023

The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis.

The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 26, 2022

The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast.

The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast.

Journal: Journal of internal medicine

Published: March 02, 2022

Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.

Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: July 29, 2021

Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs.

Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs.

Journal: Frontiers in immunology

Published: July 20, 2021

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.

Journal: Annals of the rheumatic diseases

Published: March 08, 2021

Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases.

Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases.

Journal: Antioxidants (Basel, Switzerland)

Published: February 13, 2021

Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses.

Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: December 28, 2020

Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis.

Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis.

Journal: Frontiers in immunology

Published: November 20, 2020

Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis.

Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis.

Journal: International journal of molecular sciences

Published: October 31, 2020

Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis.

Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis.

Journal: Therapeutic advances in chronic disease

Published: May 14, 2020

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.

Journal: International journal of molecular sciences

Published: February 28, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026